Abstract
The HIV–1 Tat protein transactivates HIV, viral and some host cell genes1. Tat can be released by infected cells2 and acts extracellularly in the microenvironment, regulating functions of immunocompetent and mesenchymal cells3,4. One of the most striking effects of Tat is the induction of a functional program in vascular cells related to angiogenesis and inflammation (migration, proliferation and expression of plasminogen activator inhibitor–1 and E selectin5–7). Tat induces growth of Kaposi's sarcoma (KS) spindle cells8 and is angiogenic in vivo7,9 and in transgenic mice10–12. We previously reported that Tat is a direct angiogenic factor7 and noted the Tat arginine– and lysine–rich sequence is similar to that of other potent angiogenic growth factors, such as vascular endothelial growth factor–A (VEGF–A). It is possible that Tat mimics one of these factors by interacting with its growth factor tyrosine kinase receptor. Here we demonstrate that Tat specifically binds and activates the Flk–1/kinase insert domain receptor (Flk–1/KDR), a VEGF–A tyrosine kinase receptor (for review see ref. 13), and that Tat–induced angiogenesis is blocked by agents blocking the Flk–1/KDR receptor. Endothelial cell stimulation by Tat occurs in the absence of activation of FLT–1, another VEGF–A tyrosine kinase receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vaishnaw, Y.N. & Wong-Staal, F. The biochemistry of AIDS. Annu. Rev. Biochem. 60, 577–630 (1991).
Ensoli, B. et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol 67, 277–287 (1993).
Westendorp, M.O. et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497–500 (1995).
Lotz, M., Clark-Lewis, I. & Ganu, V., HIV-transactivator Tat induces proliferation and TGF beta expression in human articular chondrocytes. J. Cell Biol. 1245, 365–371 (1994).
Barillari, G. et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149, 3727–3734 (1992).
Hofman, F.M., Dohadwala, M.M., Wright, A.D., Hinton, D.R. & Walker, S.M., Exogenous Tat protein activates central nervous system-derived endothelial cells. J. Neuroimmunol. 54, 19–28 (1994).
Albini, A. et al HIV-Tat protein is a heparin-binding angiogenic growth factor. Oncogene 12, 289–297 (1996).
Ensoli, B., Barillari, G., Salahuddin, S.Z., Gallo, R.C. & Wong-Staal, F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84–86 (1990).
Ensoli, B. et al. In vitro and in vivo evidence that basic fibroblast growth factor and human immunodeficiency virus type-1 Tat protein synergize in inducing Kaposi's sarcoma development. Nature 371, 674–680 (1994).
Vogel, J., Hinrichs, S.H., Reynolds, R.K., Luciw, P.A. & Jay, G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335, 606–611 (1988).
Corallini, A. et al. Promotion of tumor metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice. AIDS 10, 701–710 (1996).
Corallini, A. et al. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res. 53, 5569–5575 (1993).
Thomas, K.A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271, 603–606 (1996).
Albini, A. et al. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 Tat product: Inhibition of KS-like lesions by tissues inhibitor of metalloproteinase-2. AIDS 8, 1237–1244 (1994).
Mandriota, S.J. et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 270, 9709–9716 (1995).
Friedlander, M. et al. Definition of two angiogenic pathways by distinct α integrins. Science 270, 1500–1502 (1995).
Vaisman, N., Gospodarowicz, D. & Neufeld, G. Characterization of the receptors for vascular endothelial growth factor. J. Biol Chem. 265, 19461–19466 (1990).
Barnett, S.W., Murthy, K.K., Herndier, B.G. & Levy, J.A., An AIDS-like condition induced in baboons by HIV-2. Science 266, 642–646 (1994).
Moore, P. & Chang, Y. Detection of herpesvirus-like sequences in Kaposi's sarcoma in patients with and those without HIV infection. N. Engl. J. Med. 332, 1181–1185 (1995).
Safai, B. et al. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103, 744–750 (1985).
Robbins, K.C., Antoniades, H.N., Devare, S.G., Hunkapiller, M.W. & Aaronson, S.A. Structural and immunological similarities between simian virus gene product) and human platelet-derived growth factor. Nature 305, 605–608 (1983).
Kaner, R.J. et al. Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type I. Science 248, 1410–1413 (1990).
Bussolino, F. et al. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J. Clin. Invest. 96, 940–952 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albini, A., Soldi, R., Giunciuclio, D. et al. The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells. Nat Med 2, 1371–1375 (1996). https://doi.org/10.1038/nm1296-1371
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1296-1371
This article is cited by
-
Viruses exploit growth factor mechanisms to achieve augmented pathogenicity and promote tumorigenesis
Archives of Microbiology (2024)
-
Transcriptomic study reveals changes of lncRNAs in PBMCs from HIV-1 patients before and after ART
Scientific Reports (2023)
-
Extracellular Vesicle-Serpine-1 Affects Neural Progenitor Cell Mitochondrial Networks and Synaptic Density: Modulation by Amyloid Beta and HIV-1
Molecular Neurobiology (2023)
-
Disruption of blood–brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins
Journal of NeuroVirology (2023)
-
HIV Promotes Neurocognitive Impairment by Damaging the Hippocampal Microvessels
Molecular Neurobiology (2022)